Genome sequence of Xenia2 a DV cluster phage that infects Gordonia rubripertincta
Carol Agaiby, Maha Ahmed, Aidan Argueta, Kyle Arrowood, Keelynn P. Barrier, Meghan W. Church, Cheryl R. Connell, Ken D. Dao, Kathleen Huyen T. Dao, Makenzie R. Davenport, Megan D. Edmondson, Makenzie I. Estabrook, Santoshi Gondhi, Patricia Gonzalez, Francine Leduc, Trang Ma

TL;DR
This paper describes the genome of Xenia2, a virus that infects a specific type of bacteria called Gordonia rubripertincta.
Contribution
The paper provides a detailed genome sequence and analysis of a new phage, Xenia2, from the DV cluster.
Findings
Xenia2 has a genome of 68,135 base pairs with a GC content of 57.9%.
The genome includes 98 predicted protein-coding genes, 33 of which have known functions.
Abstract
Xenia2 is a DV cluster actinobacteriophage that infects Gordonia rubripertincta NRRL B-16540. The genome is 68,135bp, has a GC content of 57.9% and 98 predicted protein-coding genes, 33 of which have a predicted function. Xenia2 has a lysis cassette with an endolysin (lysin A) and four different holin-like transmembrane proteins.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Xenia2 gene number | Predicted function of protein product or domains identified | General classification of predicted protein product | Number of phamilie members | Clusters of phamilie members |
|---|---|---|---|---|
| 2 | Terminase | Enzyme | 138 | AC, AE, D, DG, DV, GG, EF, H, U, R |
| 3 | Portal protein | Phage Structural Protein | 138 | AC, AE, D, DG, DV, GG, EF, H, U, R |
| 4 | Esterase | Enzyme | 2 | DV |
| 11 | Metalloprotease | Enzyme | 35 | DV |
| 14 | Minor capsid protein | Phage Structural Protein | 125 | AC, AE, D, DG, DV, GG, EF, H |
| 15 | Major capsid protein | Phage Structural Protein | 138 | AC, AE, D, DG, DV, GG, EF, H, U, R |
| 19 | Head-to-tail stopper | Phage Structural Protein | 121 | AC, AE, D, DG, DV, GG, EF, H, U |
| 21 | Tail terminator | Phage Structural Protein | 96 | AC, AE, D, DG, DV, GG, EF, H, U, R |
| 24 | Major tail protein | Phage Structural Protein | 98 | AC, AE, D, DG, DV, GG, EF, H, U, R |
| 27 | Tape measure protein | Phage Structural Protein | 59 | DG, DV, H, U |
| 28 | Minor tail protein | Phage Structural Protein | 133 | AE, AZ, BB, DG, DV, FO, R, U |
| 29 | Minor tail protein | Phage Structural Protein | 118 | AE, AZ, BB, DG, DV, FO, R |
| 30 | Minor tail protein | Phage Structural Protein | 2 | DV |
| 33 | Lysin A | Enzyme (lysis cassette) | 178 | A, CE, CU, CY, CZ, DB, DG, DK, DP, DT, DR |
| 34 | Membrane protein | TMD protein (lysis cassette) | 38 | DG, DV |
| 35 | Membrane protein | TMD protein (lysis cassette) | 124 | CS, CY, CYZ, DB, DG, DF, DK, DO, DS, DV |
| 36 | Membrane protein | TMD protein (lysis cassette) | 232 | AD, B, CS, CZ, DB, DG, DK, DO, DR, DV, W |
| 37 | Membrane protein | TMD protein (lysis cassette) | 10 | GG, DV |
| 43 | Membrane protein | TMD protein (function unknown) | 141 | CS, CT, DC, DE, DF, DL, DO, DQ, DR, DV, DZ |
| 44 | Membrane protein | TMD protein (function unknown) | 172 | A, CR, CS, DG, DQ, DV, M |
| 58 | DNA helicase | DNA modification | 443 | AC, AE, AK, AL, BH, BN, BS, CR, CS, CX, DA, DF, DG, DK, DS, DV, EF, EJ, EN, EP, FC, GD, H, R |
| 63 | Cas4 exonuclease | DNA modification | 322 | AC, AE, AK, BH, BN, BQ, CR, D, DA, DG, DV, EA, EF, EJ, EN, H, R, U |
| 66 | ASCE ATPase | DNA modification | 204 | AC, AE, AN, CR, D, DG, DV, EF, N, H, R, U |
| 69 | Oxidoreductase | Enzyme | 116 | AE, BN, D, DG, DV, EF |
| 70 | Phosphatase | Enzyme | 74 | AE, BN, D, DV, EF |
| 72 | Methyltransferase | DNA modification | 64 | D, DG, DV |
| 75 | FabG-like reductase | DNA modification | 62 | D DV, EF |
| 79 | HNH endonuclease | DNA modification | 5 | AE, DV |
| 80 | DnaE-like DNA polymerase III alpha | DNA modification | 514 | AA, AC, AD, BD, BE, BK, BN, CB, CR, DO, DV, DX, EN, H, U |
| 81 | MazG-like nucleotide pyrophosphohydrolase | DNA modification | 35 | DV |
| 84 | ThyX-like thymidylate synthase | Enzyme | 104 | D, DG, DV, EF |
| 88 | RuvC-like resolvase | DNA modification | 210 | AC, AE, BN, BM, CR, D, DG, DV, EN, H, R, U |
| 89 | Lysin B | Enzyme | 617 | CB, CD, CG, CR, CS, CT, CV, CX, CY, CZ, DA, DB, DC, DE, DF, DG, DH, DJ, DN, DQ, DR, DT, DV, DW, DY, DZ |
| 91 | DNA primase/polymerase | DNA modification | 157 | AE, CR, D, DG, DV, EN, H, R |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBacteriophages and microbial interactions · Actinomycetales infections and treatment
ANNOUNCEMENT
Bacteriophages are viruses that infect bacteria and are currently used in fields such as agriculture, food safety, and medicine (1, 2). Phages offer a vast repository of genes, and the isolation and characterization of new phages are critical in understanding the evolution of both phage and bacterial defense mechanisms (3).
Xenia2 was isolated from moist, dark soil taken from ~1” depth in a grassy area in Tampa, Florida (28.066944 N, 82.414722 W). Phage was separated from 15 g soil by shaking at 250 rpm for 2 h in a total of 30 mL peptone-yeast calcium media (PYCa) followed by sterile filtration (0.2 µm PES). Gordonia rubripertincta NRRL B-16540 was infected with sterile filtrates and plated on PYCa agar at 30°C. Genomic DNA was isolated from a high-titer filtrate after three rounds of plaque purification using the Wizard DNA clean-up kit (A7280; Promega). Genomic DNA was used to create sequencing libraries with the NEB Ultra II Library Kit, v3 Reagents. Sequencing was performed by the Pittsburgh Bacteriophage Institute, and the library was run on an Illumina MiSeq instrument, yielding 418,773 single-end 150-base reads yielding a 921-fold average coverage. Read QC is described by Russell (4), and the genome was assembled with Newbler (v2.9) (5) and checked for completeness, accuracy, and genome termini using Consed (6). Default parameters were used for all software unless otherwise specified. Xenia2 is 68,135 bp, has 57.9% GC content, and is circularly permuted based on the lack of defined genome ends (4) and was bioinformatically linearized such that base 1 is assigned in accord with other Gordonia phage (4). Xenia2 was autoannotated using DNA master (v5.23.6) (7), and the genes were manually validated for correct starts and functional calls. GeneMark (v2.5) (8) and Glimmer (v3.02) (9) were utilized to assess start sites and coding potential and Starterator (v1.2) (10) to summarize the starts across each family of phage genes. Evidence to support a gene product function was collected using HHpred (v3.2) (11), NCBI BLAST +2.14.0 (12), and the Conserved Domain Database (v3.19) (13). Putative transmembrane domains (TMD) were identified using Deep TMHMM (14) and TOPCONS (15). The data for Xenia2 are archived in Phamerator (16) and the Actinobacteriophage Database at PhagesDB.org (10).
Xenia2 is a dsDNA tailed bacteriophage in the order Caudoviricetes that is grouped to the DV cluster by gene-content similarity (10). Xenia2 creates 0.6–1.0 mm sized plaques with rough edges after 24–36 h incubation at 30°C. The DV cluster has 35 members, and Xenia2 shares 92% gene content with DumpTruck (MZ005671), but only ~70% with the other DV phages (10, 17). Gene products with predicted functions are listed in Table 1. All DV phages encode the same endolysin (lysin A); however, Xenia2 and DumpTruck show divergence in the holin-like TMD genes. Xenia2 and DumpTruck have four TMD-encoded proteins in the lysis cassette (gp34-gp37) that have 2, 4, 4, and 1 TMD, respectively. All other DV phages have 3 TMDs, of which only the first is shared with Xenia2 and DumpTruck. Variations in the lysis cassette have been observed in other phage clusters and may impact phage fitness (18, 19).
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Shield CG, Swift BMC, Mc Hugh TD, Dedrick RM, Hatfull GF, Satta G. 2021. Application of bacteriophages for mycobacterial infections, from diagnosis to treatment. Microorganisms 9:2366. doi:10.3390/microorganisms 911236634835491 PMC 8617706 · doi ↗ · pubmed ↗
- 2Wang Z, Zhao X. 2022. The application and research progress of bacteriophages in food safety. J Appl Microbiol 133:2137–2147. doi:10.1111/jam.1555535353432 · doi ↗ · pubmed ↗
- 3Watson BNJ, Steens JA, Staals RHJ, Westra ER, van Houte S. 2021. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages. Cell Host Microbe 29:715–725. doi:10.1016/j.chom.2021.03.01833984274 · doi ↗ · pubmed ↗
- 4Russel DA, et al.. 2018. Sequencing, assembling, and finishing complete bacteriophage genomes. from bacteriophages: methods and protocols. In Clokie Martha RJ (ed), Volume 3, methods in molecular biology. Vol. 1681.10.1007/978-1-4939-7343-9_929134591 · doi ↗ · pubmed ↗
- 5Genivaldo GZ, Silva BE, Dutilh D, Matthews K, Elkins R, Schmieder EA, Dinsdale RAE. 2013. Combining de novo and reference-guided assembly with scaffold_builder. Source Code Biol Med 8:23. doi:10.1186/1751-0473-8-2324267787 PMC 4177539 · doi ↗ · pubmed ↗
- 6Gordon D, Abajian C, Green P. 1998. Consed: a graphical tool for sequence finishing. Genome Res 8:195–202. doi:10.1101/gr.8.3.1959521923 · doi ↗ · pubmed ↗
- 7Pope WH, Jacobs-Sera D. 2018. Annotation of bacteriophage genome sequences using DNA master: an overview. Methods Mol Biol 1681:217–229. doi:10.1007/978-1-4939-7343-9_1629134598 · doi ↗ · pubmed ↗
- 8Besemer J, Borodovsky M. 2005. Gene Mark: web software for gene finding in prokaryotes, eukaryotes and viruses. Nucleic Acids Res 33:W 451–4. doi:10.1093/nar/gki 48715980510 PMC 1160247 · doi ↗ · pubmed ↗
